Hospital
Clifton-Fine Healthcare Corporation
Clifton-Fine Healthcare Corporation was paid $1.18M by Medicaid between Jan 2018 and Nov 2024, across 35 billing codes. Its largest line is 36415, Collection of venous blood by venipuncture — 27% of everything it billed.
33Billing provider infoCLIFTON-FINE HEALTHCARE CORPORATION
STAR LAKE, NY 13690
STAR LAKE, NY 13690
33aNPI1235184649assigned 05/23/2006
33bProvider typeRural Acute Care Hospital
28Total paid$1.18M
24GClaims16,109
24DCodes billed35
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Rural Acute Care Hospital providers in New York
Rank by total paid#6 of 7
Median peer was paid$13.87M
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 644 | $27K | |
| 2019 | 1,412 | $44K | |
| 2020 | 1,519 | $34K | |
| 2021 | 2,799 | $92K | |
| 2022 | 3,530 | $561K | |
| 2023 | 3,554 | $293K | |
| 2024incomplete | 2,651 | $128K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 36415 | Collection of venous blood by venipuncture | 27% | 2,581 | 2,301 | $323K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 21% | 2,452 | 2,267 | $251K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 19% | 673 | 633 | $222K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.2% | 660 | 610 | $97K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.0% | 654 | 632 | $82K |
| 80053 | Comprehensive metabolic panel | 4.2% | 1,624 | 1,534 | $50K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.7% | 818 | 757 | $31K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.7% | 132 | 124 | $20K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.4% | 473 | 468 | $16K |
| 80061 | Lipid panel | 1.3% | 900 | 893 | $15K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.1% | 818 | 798 | $13K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.1% | 234 | 214 | $12K |
23 more codes
| G0306 | Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count | <1% | 1,459 | $10K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 103 | $8K |
| 99284 | Emergency room visit (serious) | <1% | 61 | $7K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 860 | $5K |
| 84439 | <1% | 333 | $5K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 100 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 333 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 62 | $2K |
| 99285 | Emergency room visit (most serious) | <1% | 13 | $1K |
| 81001 | <1% | 345 | $1K | |
| 90686 | <1% | 26 | $688.56 | |
| 82607 | <1% | 24 | $493.74 | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 26 | $405.54 |
| 85652 | <1% | 39 | $255.14 | |
| 86140 | <1% | 40 | $227.03 | |
| 82043 | <1% | 14 | $135.86 | |
| 82728 | <1% | 12 | $116.80 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 33 | $97.04 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 97 | $64.77 |
| 83540 | <1% | 13 | $55.63 | |
| 81000 | <1% | 25 | $46.16 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 55 | $0.00 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSORRELL, DIERDRA (CEO)